首页 > 最新文献

Korean journal of clinical oncology最新文献

英文 中文
Utility of sentinel lymph node biopsy in papillary thyroid microcarcinoma. 前哨淋巴结活检在甲状腺乳头状微癌中的应用。
Pub Date : 2021-12-01 DOI: 10.14216/kjco.21018
Hyun Yul Kim, Dong-Il Kim, Chang Shin Jung, Seung Joo Lee, Dong Won Im, Youn Joo Jung, Jeong-A Yeom, Jeong Bum Choi

Purpose: There are many studies on sentinel lymph node (SLN) biopsy in thyroid carcinoma but SLN biopsy (SLNB) in papillary thyroid carcinoma (PTC) remains open to debate. Therefore in this retrospective study, the usefulness of SLNB in thyroid carcinoma patients who had micro-PTC without cervical lymphadenopathy was assessed.

Methods: SLNB was performed in 114 patients who were diagnosed with micro-PTC in a single lobe without palpable or ultrasound-detected lymph node at the tertiary center between January 2012 and December 2013. After SLNB, all patients underwent total thyroidectomy and central neck dissection or thyroid lobectomy and central neck dissection of the single side.

Results: SLNs were identified in 112 of 114 patients with 41 positive SLNs and 71 negative SLNs on intraoperative frozen sections. However, eight negative patients were found to be positive in the final pathology. Sentinel node identification rate and false negative value of SLNB were 98.2% and 11.3%, respectively. In the univariate analysis, higher lymph node metastasis was detected in men than in women. Higher detection number of SLN showed higher probability of lymph node metastasis.

Conclusion: SLNB may be helpful in papillary thyroid cancer, especially in male patients. Also, it is useful for the staging of nodal status and clearance of persistent disease.

目的:甲状腺癌前哨淋巴结(SLN)活检的研究很多,但甲状腺乳头状癌(PTC)的SLN活检(SLNB)仍有争议。因此,在本回顾性研究中,我们评估了SLNB在甲状腺癌微ptc无颈部淋巴结病变患者中的应用价值。方法:对2012年1月至2013年12月在第三中心诊断为单叶微ptc且未触及或超声检查淋巴结的114例患者行SLNB。SLNB术后,所有患者均行甲状腺全切除术合并中央颈清扫或单侧甲状腺小叶切除术合并中央颈清扫。结果:114例患者中,术中冰冻切片发现sln阳性41例,sln阴性71例,其中112例为sln。然而,8例阴性患者在最终病理中发现阳性。SLNB前哨淋巴结检出率为98.2%,假阴性值为11.3%。在单变量分析中,男性的淋巴结转移率高于女性。SLN的检测次数越多,淋巴结转移的可能性越大。结论:SLNB对男性甲状腺乳头状癌有一定的治疗作用。此外,它对淋巴结状态的分期和持续性疾病的清除也很有用。
{"title":"Utility of sentinel lymph node biopsy in papillary thyroid microcarcinoma.","authors":"Hyun Yul Kim,&nbsp;Dong-Il Kim,&nbsp;Chang Shin Jung,&nbsp;Seung Joo Lee,&nbsp;Dong Won Im,&nbsp;Youn Joo Jung,&nbsp;Jeong-A Yeom,&nbsp;Jeong Bum Choi","doi":"10.14216/kjco.21018","DOIUrl":"https://doi.org/10.14216/kjco.21018","url":null,"abstract":"<p><strong>Purpose: </strong>There are many studies on sentinel lymph node (SLN) biopsy in thyroid carcinoma but SLN biopsy (SLNB) in papillary thyroid carcinoma (PTC) remains open to debate. Therefore in this retrospective study, the usefulness of SLNB in thyroid carcinoma patients who had micro-PTC without cervical lymphadenopathy was assessed.</p><p><strong>Methods: </strong>SLNB was performed in 114 patients who were diagnosed with micro-PTC in a single lobe without palpable or ultrasound-detected lymph node at the tertiary center between January 2012 and December 2013. After SLNB, all patients underwent total thyroidectomy and central neck dissection or thyroid lobectomy and central neck dissection of the single side.</p><p><strong>Results: </strong>SLNs were identified in 112 of 114 patients with 41 positive SLNs and 71 negative SLNs on intraoperative frozen sections. However, eight negative patients were found to be positive in the final pathology. Sentinel node identification rate and false negative value of SLNB were 98.2% and 11.3%, respectively. In the univariate analysis, higher lymph node metastasis was detected in men than in women. Higher detection number of SLN showed higher probability of lymph node metastasis.</p><p><strong>Conclusion: </strong>SLNB may be helpful in papillary thyroid cancer, especially in male patients. Also, it is useful for the staging of nodal status and clearance of persistent disease.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d8/15/kjco-17-2-117.PMC9942750.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9513463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initial experience with laparoscopic posterior retroperitoneal adrenalectomy in single tertiary center. 单三级中心腹腔镜后腹膜肾上腺切除术的初步经验。
Pub Date : 2021-12-01 DOI: 10.14216/kjco.21014
Jeong Hee Han, Byoung Chul Lee, Young Mok Park, Hyuk Jae Jung, Dong-Il Kim, Jung Bum Choi

Purpose: Laparoscopic posterior retroperitoneal adrenalectomy (LPRA) is a surgical method that accesses the adrenal gland through the back. The aim of this study was to report initial experience of LPRA and evaluate possibilities for surgical application.

Methods: From March 2018 to December 2019, a total of 30 consecutive patients diagnosed with adrenal tumor underwent surgical treatment at Pusan National University Hospital were enrolled. Clinicopathologic features and various peri- and postoperative parameters were analyzed by retrospective medical record review. The mean age of the patients was 48.20±13.66 years.

Results: The mean body mass index (BMI) was 25.50±4.30 kg/m2. Primary hyperaldosteronism was the most frequently preoperative diagnosed disease (n=13, 43.4%), followed by adrenal incidentaloma (n=8, 26.6%), Cushing syndrome (n=5, 16.6%) and pheochromocytoma (n=4, 13.3%). The mean size of postoperative adrenal tumor was 2.72±1.76 cm. The mean operating time was 162±58.14 minutes. Among the 30 patients, 28 patients underwent total adrenalectomy (93.3%) and two patients underwent cortical sparing adrenalectomy (6.7%). When LPRA was performed for patients with BMI >23.16 kg/m2, the operating time was longer than the average (P=0.016).

Conclusion: LPRA was suitable and safe for patients with benign adrenal tumors. BMI, retroperitoneal fat density and postoperative adrenal weight may be related to the operating time, so they should be considered when deciding on a surgical method for adrenalectomy.

目的:腹腔镜后腹膜后肾上腺切除术(LPRA)是一种经背部进入肾上腺的手术方法。本研究的目的是报告LPRA的初步经验,并评估手术应用的可能性。方法:2018年3月至2019年12月,在釜山国立大学医院连续诊断为肾上腺肿瘤并接受手术治疗的患者共30例。通过回顾性病历分析临床病理特征和各种围手术期及术后参数。患者平均年龄48.20±13.66岁。结果:平均体重指数(BMI)为25.50±4.30 kg/m2。原发性醛固酮增多症是术前诊断最多的疾病(n=13, 43.4%),其次是肾上腺偶发瘤(n=8, 26.6%)、库欣综合征(n=5, 16.6%)和嗜铬细胞瘤(n=4, 13.3%)。术后肾上腺肿瘤平均大小为2.72±1.76 cm。平均手术时间162±58.14 min。30例患者中,28例行全肾上腺切除术(93.3%),2例行保留肾上腺皮质切除术(6.7%)。BMI >23.16 kg/m2的患者行LPRA时,手术时间较平均时间长(P=0.016)。结论:LPRA治疗肾上腺良性肿瘤是安全可行的。BMI、腹膜后脂肪密度和术后肾上腺重量可能与手术时间有关,因此在决定肾上腺切除术的手术方式时应考虑这些因素。
{"title":"Initial experience with laparoscopic posterior retroperitoneal adrenalectomy in single tertiary center.","authors":"Jeong Hee Han,&nbsp;Byoung Chul Lee,&nbsp;Young Mok Park,&nbsp;Hyuk Jae Jung,&nbsp;Dong-Il Kim,&nbsp;Jung Bum Choi","doi":"10.14216/kjco.21014","DOIUrl":"https://doi.org/10.14216/kjco.21014","url":null,"abstract":"<p><strong>Purpose: </strong>Laparoscopic posterior retroperitoneal adrenalectomy (LPRA) is a surgical method that accesses the adrenal gland through the back. The aim of this study was to report initial experience of LPRA and evaluate possibilities for surgical application.</p><p><strong>Methods: </strong>From March 2018 to December 2019, a total of 30 consecutive patients diagnosed with adrenal tumor underwent surgical treatment at Pusan National University Hospital were enrolled. Clinicopathologic features and various peri- and postoperative parameters were analyzed by retrospective medical record review. The mean age of the patients was 48.20±13.66 years.</p><p><strong>Results: </strong>The mean body mass index (BMI) was 25.50±4.30 kg/m<sup>2</sup>. Primary hyperaldosteronism was the most frequently preoperative diagnosed disease (n=13, 43.4%), followed by adrenal incidentaloma (n=8, 26.6%), Cushing syndrome (n=5, 16.6%) and pheochromocytoma (n=4, 13.3%). The mean size of postoperative adrenal tumor was 2.72±1.76 cm. The mean operating time was 162±58.14 minutes. Among the 30 patients, 28 patients underwent total adrenalectomy (93.3%) and two patients underwent cortical sparing adrenalectomy (6.7%). When LPRA was performed for patients with BMI >23.16 kg/m<sup>2</sup>, the operating time was longer than the average (P=0.016).</p><p><strong>Conclusion: </strong>LPRA was suitable and safe for patients with benign adrenal tumors. BMI, retroperitoneal fat density and postoperative adrenal weight may be related to the operating time, so they should be considered when deciding on a surgical method for adrenalectomy.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/72/kjco-17-2-90.PMC9942749.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9158594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical relevance and prognostic role of preoperative cell-free single-stranded DNA concentrations in colorectal cancer patients. 结直肠癌患者术前细胞游离单链DNA浓度的临床相关性和预后作用
Pub Date : 2021-12-01 DOI: 10.14216/kjco.21010
Hyun Soo Song, Dong Hyun Kang, Hyunjung Kim, Tae Sung Ahn, Tae Wan Kim, Moo-Jun Baek

Purpose: Circulating cell-free single-stranded DNA (ccf-ssDNA) is extracellular DNA and it is a useful biomarker for the diagnosis of tumors and predicting the prognosis of tumors. However, the clinical usefulness of ccf-ssDNA in colorectal cancer (CRC) is not well known. Thus, the purpose of this study was to investigate the clinical usefulness of ccf-ssDNA in CRC.

Methods: The study was conducted on 44 patients who had undergone surgery for CRC, and ccf-ssDNA level was measured before surgery and statistical analysis was performed on clinical factors.

Results: The association between ccf-ssDNA level and clinicopathological factors was analyzed and compared, and these factors included age, sex, body mass index, diabetes mellitus, hypertension, tumor markers (carcinoembryonic antigen and carbohydrate antigen 19-9), tumor location, size, stage (TNM), recurrence, and death. The group with a ccf-ssDNA level of ≥7.5 ng/μL had a lower age (P=0.010), and was associated with diabetes mellitus (P=0.037) and lymph node metastasis (P=0.049). Multivariate analysis of disease-free survival showed that lymph node metastasis and ccf-ssDNA level (hazard ratio, 10.011; 95% confidence interval, 2.269-44.175; P=0.002) were independent prognostic factors for recurrence. In terms of overall survival, there were no statistically significant results except for vascular invasion.

Conclusion: This study showed that ccf-ssDNA level in plasma in CRC patients was an independent prognostic factor that could predict recurrence non-invasively. In this regard, further evaluation with a prospective, large sample size study will be needed to obtain additional results.

目的:循环细胞游离单链DNA (ccf-ssDNA)是一种细胞外DNA,是肿瘤诊断和预测肿瘤预后的重要生物标志物。然而,ccf-ssDNA在结直肠癌(CRC)中的临床应用尚不清楚。因此,本研究的目的是探讨ccf-ssDNA在结直肠癌中的临床应用。方法:对44例结直肠癌手术患者进行研究,术前检测ccf-ssDNA水平,并对临床因素进行统计分析。结果:分析比较ccf-ssDNA水平与年龄、性别、体重指数、糖尿病、高血压、肿瘤标志物(癌胚抗原和碳水化合物抗原19-9)、肿瘤位置、大小、分期(TNM)、复发、死亡等临床病理因素的相关性。ccf-ssDNA≥7.5 ng/μL组年龄较低(P=0.010),且与糖尿病(P=0.037)和淋巴结转移(P=0.049)相关。无病生存的多因素分析显示淋巴结转移和ccf-ssDNA水平(风险比,10.011;95%置信区间为2.269-44.175;P=0.002)是复发的独立预后因素。在总生存率方面,除血管侵犯外,无统计学意义。结论:本研究显示CRC患者血浆ccf-ssDNA水平是一个独立的预后因素,可无创预测CRC复发。在这方面,需要进行前瞻性、大样本量研究的进一步评价,以获得更多的结果。
{"title":"Clinical relevance and prognostic role of preoperative cell-free single-stranded DNA concentrations in colorectal cancer patients.","authors":"Hyun Soo Song,&nbsp;Dong Hyun Kang,&nbsp;Hyunjung Kim,&nbsp;Tae Sung Ahn,&nbsp;Tae Wan Kim,&nbsp;Moo-Jun Baek","doi":"10.14216/kjco.21010","DOIUrl":"https://doi.org/10.14216/kjco.21010","url":null,"abstract":"<p><strong>Purpose: </strong>Circulating cell-free single-stranded DNA (ccf-ssDNA) is extracellular DNA and it is a useful biomarker for the diagnosis of tumors and predicting the prognosis of tumors. However, the clinical usefulness of ccf-ssDNA in colorectal cancer (CRC) is not well known. Thus, the purpose of this study was to investigate the clinical usefulness of ccf-ssDNA in CRC.</p><p><strong>Methods: </strong>The study was conducted on 44 patients who had undergone surgery for CRC, and ccf-ssDNA level was measured before surgery and statistical analysis was performed on clinical factors.</p><p><strong>Results: </strong>The association between ccf-ssDNA level and clinicopathological factors was analyzed and compared, and these factors included age, sex, body mass index, diabetes mellitus, hypertension, tumor markers (carcinoembryonic antigen and carbohydrate antigen 19-9), tumor location, size, stage (TNM), recurrence, and death. The group with a ccf-ssDNA level of ≥7.5 ng/μL had a lower age (P=0.010), and was associated with diabetes mellitus (P=0.037) and lymph node metastasis (P=0.049). Multivariate analysis of disease-free survival showed that lymph node metastasis and ccf-ssDNA level (hazard ratio, 10.011; 95% confidence interval, 2.269-44.175; P=0.002) were independent prognostic factors for recurrence. In terms of overall survival, there were no statistically significant results except for vascular invasion.</p><p><strong>Conclusion: </strong>This study showed that ccf-ssDNA level in plasma in CRC patients was an independent prognostic factor that could predict recurrence non-invasively. In this regard, further evaluation with a prospective, large sample size study will be needed to obtain additional results.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/64/e5/kjco-17-2-59.PMC9942756.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9529542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Video-assisted transthoracic liver resection in patients with marginal liver function: a retrospective cohort study. 视频辅助经胸肝切除术治疗边缘性肝功能患者:一项回顾性队列研究。
Pub Date : 2021-12-01 DOI: 10.14216/kjco.21019
Ryong Ho Jung, Hyug Won Kim, Sam-Youl Yoon

Purpose: Laparoscopic hepatectomy has been widely performed by hepatobiliary surgeons for malignancy of liver and gained wide acceptance for various liver tumors, thanks to advances in surgical techniques and devices. But, there are some challenges for right side tumor in patients of cirrhotic liver. Especially, tumor located in right upper area is difficult for wedge resection in patients with marginal liver function, because trans-abdominal approach requires normal parenchymal dissection. Radiofrequency wave ablation is also difficult for such a lesion. So, we demonstrate unique technique of video-assisted transthoracic liver resection (VTLR) for overcome right upper side tumor abutting diaphragm.

Methods: Four patients underwent VTLR. Four ports in right chest wall were created by a chest surgeon and diaphragm was open. Then traction of the diaphragm was done by suture. After exposure of liver surface, tumor localization was done by ultrasound. The mass excision was done by ultrasonic shear.

Results: Four patients were discharged without complications within 11.3 days (range, 6-15 days). On average, patients started to consume a normal diet on an average of 2.4 days (range, 1-4 days).

Conclusion: VTLR is could be performed by an experienced surgeon and chest surgeon for right upper liver malignancy abutting diaphragm in patient of marginal liver function.

目的:由于手术技术和设备的进步,腹腔镜肝切除术已被肝胆外科医生广泛应用于肝脏恶性肿瘤,并在各种肝脏肿瘤中得到广泛接受。但是,肝硬化患者右侧肿瘤的治疗存在一些挑战。特别是肝功能边缘的患者,肿瘤位于右上区,很难进行楔形切除,因为经腹入路需要正常的肝实质清扫。射频波消融对于这种病变也是困难的。因此,我们展示了一种独特的视频辅助经胸肝切除术(VTLR)来克服右上侧肿瘤毗邻隔膜。方法:4例患者行带瓣复诊。胸外科医生在右胸壁开了四个口,打开了横膈膜。然后用缝线牵引膈肌。肝表面暴露后,超声定位肿瘤。超声切割机切除肿块。结果:4例患者均在11.3天(范围6 ~ 15天)内出院,无并发症。患者开始正常饮食的平均时间为2.4天(范围1-4天)。结论:有经验的外科医生和胸外科医生可对边缘性肝功能患者的右上肝恶性肿瘤邻近膈肌进行全肺切除。
{"title":"Video-assisted transthoracic liver resection in patients with marginal liver function: a retrospective cohort study.","authors":"Ryong Ho Jung,&nbsp;Hyug Won Kim,&nbsp;Sam-Youl Yoon","doi":"10.14216/kjco.21019","DOIUrl":"https://doi.org/10.14216/kjco.21019","url":null,"abstract":"<p><strong>Purpose: </strong>Laparoscopic hepatectomy has been widely performed by hepatobiliary surgeons for malignancy of liver and gained wide acceptance for various liver tumors, thanks to advances in surgical techniques and devices. But, there are some challenges for right side tumor in patients of cirrhotic liver. Especially, tumor located in right upper area is difficult for wedge resection in patients with marginal liver function, because trans-abdominal approach requires normal parenchymal dissection. Radiofrequency wave ablation is also difficult for such a lesion. So, we demonstrate unique technique of video-assisted transthoracic liver resection (VTLR) for overcome right upper side tumor abutting diaphragm.</p><p><strong>Methods: </strong>Four patients underwent VTLR. Four ports in right chest wall were created by a chest surgeon and diaphragm was open. Then traction of the diaphragm was done by suture. After exposure of liver surface, tumor localization was done by ultrasound. The mass excision was done by ultrasonic shear.</p><p><strong>Results: </strong>Four patients were discharged without complications within 11.3 days (range, 6-15 days). On average, patients started to consume a normal diet on an average of 2.4 days (range, 1-4 days).</p><p><strong>Conclusion: </strong>VTLR is could be performed by an experienced surgeon and chest surgeon for right upper liver malignancy abutting diaphragm in patient of marginal liver function.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3c/f1/kjco-17-2-122.PMC9942747.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9529538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-course radiotherapy and chemotherapy for conversion surgery in patients with unresectable metastatic rectal cancer: a preliminary case series study. 不可切除的转移性直肠癌转换手术患者的短期放疗和化疗:初步病例系列研究。
Pub Date : 2021-12-01 DOI: 10.14216/kjco.21017
Youngbae Jeon, Kyoung-Won Han, Seok Ho Lee, Sun Jin Sym, Seung Joon Choi, Seung Yeon Ha, Jeong-Heum Baek

Purpose: Curative treatment is challenging in patients with locally advanced rectal cancer and unresectable metastases. The aim of this study was to evaluate the clinical outcomes of short-course radiotherapy (RT) followed by systemic chemotherapy for patients with rectal cancer with mesorectal fascia (MRF) involvement and unresectable distant metastases.

Methods: The study included consecutive patients diagnosed as having metastatic mid-to-low rectal cancer treated with short-course RT followed by systemic chemotherapy for conversion radical or palliative surgery between 2014 and 2019 at Gil Medical Center. The patients had primary rectal tumors involving the MRF and unresectable distant metastases. The treatment strategies were determined in a multidisciplinary team discussion.

Results: Seven patients (five men and two women) underwent short-course RT (5×5 Gy) and preoperative systemic chemotherapy. The median age was 68 years (range, 46-84 years), and the median distance from the anal verge to the primary tumor was 6.0 cm (range, 2.0-9.0 cm). During the median follow-up period of 29.4 months, three patients underwent conversion radical surgery with R0 resection, two underwent palliative surgery, and two could not undergo surgery. No postoperative major morbidity or mortality occurred. The patients who underwent conversion complete radical surgery showed good long-term survival outcomes, with an overall survival time of 29.4-48.8 months and progression-free survival time of 14.7-41.1 months.

Conclusion: Short-course RT followed by systemic chemotherapy could provide patients with unresectable stage IV rectal cancer a chance to undergo to conversion radical surgery with good long-term survival outcomes.

目的:在局部晚期直肠癌和不可切除转移的患者中,治疗是具有挑战性的。本研究的目的是评估短期放疗(RT)后全身化疗对直肠系膜筋膜(MRF)受损伤和不能切除的远处转移的直肠癌患者的临床结果。方法:该研究纳入了2014年至2019年在吉尔医疗中心诊断为转移性中低位直肠癌的连续患者,这些患者接受了短期RT治疗,随后进行了全身化疗,以进行根治性或姑息性手术。患者原发直肠肿瘤累及MRF和不可切除的远处转移。治疗策略是在多学科小组讨论中确定的。结果:7例患者(5男2女)接受了短期放射治疗(5×5 Gy)和术前全身化疗。中位年龄为68岁(范围46 ~ 84岁),肛门边缘到原发肿瘤的中位距离为6.0 cm(范围2.0 ~ 9.0 cm)。在29.4个月的中位随访期间,3例患者行R0根治性手术,2例行姑息性手术,2例不能行手术。术后无重大发病率或死亡率发生。接受完全根治性手术的患者长期生存结果良好,总生存时间为29.4 ~ 48.8个月,无进展生存时间为14.7 ~ 41.1个月。结论:短期放射治疗加全身化疗可为无法切除的IV期直肠癌患者提供接受根治性手术的机会,并具有良好的长期生存预后。
{"title":"Short-course radiotherapy and chemotherapy for conversion surgery in patients with unresectable metastatic rectal cancer: a preliminary case series study.","authors":"Youngbae Jeon,&nbsp;Kyoung-Won Han,&nbsp;Seok Ho Lee,&nbsp;Sun Jin Sym,&nbsp;Seung Joon Choi,&nbsp;Seung Yeon Ha,&nbsp;Jeong-Heum Baek","doi":"10.14216/kjco.21017","DOIUrl":"https://doi.org/10.14216/kjco.21017","url":null,"abstract":"<p><strong>Purpose: </strong>Curative treatment is challenging in patients with locally advanced rectal cancer and unresectable metastases. The aim of this study was to evaluate the clinical outcomes of short-course radiotherapy (RT) followed by systemic chemotherapy for patients with rectal cancer with mesorectal fascia (MRF) involvement and unresectable distant metastases.</p><p><strong>Methods: </strong>The study included consecutive patients diagnosed as having metastatic mid-to-low rectal cancer treated with short-course RT followed by systemic chemotherapy for conversion radical or palliative surgery between 2014 and 2019 at Gil Medical Center. The patients had primary rectal tumors involving the MRF and unresectable distant metastases. The treatment strategies were determined in a multidisciplinary team discussion.</p><p><strong>Results: </strong>Seven patients (five men and two women) underwent short-course RT (5×5 Gy) and preoperative systemic chemotherapy. The median age was 68 years (range, 46-84 years), and the median distance from the anal verge to the primary tumor was 6.0 cm (range, 2.0-9.0 cm). During the median follow-up period of 29.4 months, three patients underwent conversion radical surgery with R0 resection, two underwent palliative surgery, and two could not undergo surgery. No postoperative major morbidity or mortality occurred. The patients who underwent conversion complete radical surgery showed good long-term survival outcomes, with an overall survival time of 29.4-48.8 months and progression-free survival time of 14.7-41.1 months.</p><p><strong>Conclusion: </strong>Short-course RT followed by systemic chemotherapy could provide patients with unresectable stage IV rectal cancer a chance to undergo to conversion radical surgery with good long-term survival outcomes.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9b/9c/kjco-17-2-111.PMC9942748.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9529540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic significance of splenectomy during completion total gastrectomy in patients with remnant gastric cancer: propensity score matching analysis. 残余胃癌完全全胃切除术中脾切除术的预后意义:倾向评分匹配分析。
Pub Date : 2021-12-01 DOI: 10.14216/kjco.21015
Seung Hyun Back, Sung Eun Oh, Ji Yeong An, Min-Gew Choi, Tae Sung Sohn, Jae Moon Bae, Jun Ho Lee

Purpose: Splenectomy for patients with remnant gastric cancer has been controversial. The purpose of this study is to identify the impact of splenectomy in the treatment of remnant gastric cancer.

Methods: We retrospectively analyzed 285 patients with remnant gastric cancer who underwent completion total gastrectomy with or without splenectomy in Samsung Medical Center, between September 1996 and December 2017. We used a 1:1 propensity score matching method for the analysis. The matching factors were age, sex, and pathologic stage. After the matching process, we compared the 5-year overall survival (OS) and the disease-free survival (DFS) between patients with and without splenectomy during completion total gastrectomy.

Results: The median duration of follow-up was 58.0 months (range, 0-132 months). After propensity score matching, there were no statistically significant differences between the splenectomy group (n=77) and no splenectomy group (n=77) in terms of clinicopathological features. The 5-year OS rate between the no splenectomy and splenectomy group were not significantly different. There was no significant difference between 5-year DFS of the matched groups. Multivariate analysis revealed that splenectomy is not a significant prognostic factor in terms of 5-year OS (no splenectomy vs. splenectomy; 61.5% vs. 60.2%, P=0.884) or DFS (74.9% vs. 69.8%, P=0.880).

Conclusion: Splenectomy has no impact on the OS and DFS in patients with remnant gastric cancer. Splenectomy during completion total gastrectomy may not be necessary.

目的:残余胃癌的脾切除术一直存在争议。本研究的目的是确定脾切除术在残余胃癌治疗中的影响。方法:回顾性分析1996年9月至2017年12月在三星医疗中心行完整全胃切除或不切除脾的285例残余胃癌患者。我们使用1:1倾向评分匹配方法进行分析。匹配因素为年龄、性别、病理分期。在匹配过程后,我们比较了完成全胃切除术中脾切除术和不脾切除术患者的5年总生存期(OS)和无病生存期(DFS)。结果:中位随访时间为58.0个月(范围0-132个月)。倾向评分匹配后,脾切除术组(n=77)与未脾切除术组(n=77)的临床病理特征差异无统计学意义。未脾切除术组与脾切除术组的5年生存率无显著性差异。配对组5年DFS差异无统计学意义。多因素分析显示,脾切除术不是5年OS的重要预后因素(未脾切除术vs.脾切除术;61.5%比60.2%,P = 0.884)或DFS(74.9%比69.8%,P = 0.880)。结论:脾切除术对残胃癌患者的OS和DFS无影响。完全性全胃切除术期间可能不需要脾切除术。
{"title":"Prognostic significance of splenectomy during completion total gastrectomy in patients with remnant gastric cancer: propensity score matching analysis.","authors":"Seung Hyun Back,&nbsp;Sung Eun Oh,&nbsp;Ji Yeong An,&nbsp;Min-Gew Choi,&nbsp;Tae Sung Sohn,&nbsp;Jae Moon Bae,&nbsp;Jun Ho Lee","doi":"10.14216/kjco.21015","DOIUrl":"https://doi.org/10.14216/kjco.21015","url":null,"abstract":"<p><strong>Purpose: </strong>Splenectomy for patients with remnant gastric cancer has been controversial. The purpose of this study is to identify the impact of splenectomy in the treatment of remnant gastric cancer.</p><p><strong>Methods: </strong>We retrospectively analyzed 285 patients with remnant gastric cancer who underwent completion total gastrectomy with or without splenectomy in Samsung Medical Center, between September 1996 and December 2017. We used a 1:1 propensity score matching method for the analysis. The matching factors were age, sex, and pathologic stage. After the matching process, we compared the 5-year overall survival (OS) and the disease-free survival (DFS) between patients with and without splenectomy during completion total gastrectomy.</p><p><strong>Results: </strong>The median duration of follow-up was 58.0 months (range, 0-132 months). After propensity score matching, there were no statistically significant differences between the splenectomy group (n=77) and no splenectomy group (n=77) in terms of clinicopathological features. The 5-year OS rate between the no splenectomy and splenectomy group were not significantly different. There was no significant difference between 5-year DFS of the matched groups. Multivariate analysis revealed that splenectomy is not a significant prognostic factor in terms of 5-year OS (no splenectomy vs. splenectomy; 61.5% vs. 60.2%, P=0.884) or DFS (74.9% vs. 69.8%, P=0.880).</p><p><strong>Conclusion: </strong>Splenectomy has no impact on the OS and DFS in patients with remnant gastric cancer. Splenectomy during completion total gastrectomy may not be necessary.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/83/18/kjco-17-2-96.PMC9942751.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9529541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare case of postoperative mediastinitis following thyroidectomy. 甲状腺切除术后纵隔炎罕见病例。
Pub Date : 2021-06-01 DOI: 10.14216/kjco.21009
In Soo Cho, Moo Hyun Lee, Jihyoung Cho

Descending necrotizing mediastinitis (DNM) is a life-threatening complication secondary to oropharyngeal abscesses, cervical esophageal perforation, or neck infections spreading along the fascial planes into the mediastinum. Post-thyroidectomy surgical site infection is a highly unusual complication that is typically localized around the incision, but may be propagated into the mediastinum, causing DNM. We encountered a case of this rare complication after thyroidectomy. The patient was a 33-year-old woman who was admitted to our center for left hemithyroidectomy. The surgery was performed without any intraoperative events. However, she later developed fever, hypotension, and tachycardia. Imaging revealed deep neck emphysema and focal pneumomediastinum with infiltration in the anterior neck and mediastinum with abscess formation. Additional imaging at 7 days postoperatively revealed reduced fluid collection deep in the neck with minimal changes in fluid collection in the mediastinum. Esophageal perforation was excluded via an esophagogram, which lead to the conclusion that the infection may have been caused by open thyroidectomy. The patient was treated with prompt medical and surgical intervention. After treatment, she was discharged from the hospital with no further complications. We present our case report as well as a literature review of the diagnosis and treatment of this disease.

下行坏死性纵隔炎(DNM)是一种危及生命的并发症,继发于口咽脓肿、颈部食管穿孔或沿筋膜平面扩散到纵隔的颈部感染。甲状腺切除术后手术部位感染是一种非常罕见的并发症,通常局限于切口周围,但也可能扩散到纵隔,导致DNM。我们在甲状腺切除术后遇到一例这种罕见的并发症。患者是一名33岁的女性,因左侧甲状腺切除术而入院。手术无任何术中事件发生。然而,她后来出现发烧、低血压和心动过速。影像显示深颈肺气肿及局灶性纵隔气肿伴前颈浸润及纵隔脓肿形成。术后7天的附加成像显示颈部深部积液减少,纵隔积液变化很小。经食管造影排除食管穿孔,推测感染可能是开放性甲状腺切除术所致。患者得到了及时的医疗和手术治疗。经治疗后,她出院,无其他并发症。我们提出我们的病例报告,以及诊断和治疗这种疾病的文献综述。
{"title":"Rare case of postoperative mediastinitis following thyroidectomy.","authors":"In Soo Cho,&nbsp;Moo Hyun Lee,&nbsp;Jihyoung Cho","doi":"10.14216/kjco.21009","DOIUrl":"https://doi.org/10.14216/kjco.21009","url":null,"abstract":"<p><p>Descending necrotizing mediastinitis (DNM) is a life-threatening complication secondary to oropharyngeal abscesses, cervical esophageal perforation, or neck infections spreading along the fascial planes into the mediastinum. Post-thyroidectomy surgical site infection is a highly unusual complication that is typically localized around the incision, but may be propagated into the mediastinum, causing DNM. We encountered a case of this rare complication after thyroidectomy. The patient was a 33-year-old woman who was admitted to our center for left hemithyroidectomy. The surgery was performed without any intraoperative events. However, she later developed fever, hypotension, and tachycardia. Imaging revealed deep neck emphysema and focal pneumomediastinum with infiltration in the anterior neck and mediastinum with abscess formation. Additional imaging at 7 days postoperatively revealed reduced fluid collection deep in the neck with minimal changes in fluid collection in the mediastinum. Esophageal perforation was excluded via an esophagogram, which lead to the conclusion that the infection may have been caused by open thyroidectomy. The patient was treated with prompt medical and surgical intervention. After treatment, she was discharged from the hospital with no further complications. We present our case report as well as a literature review of the diagnosis and treatment of this disease.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/64/62/kjco-17-1-52.PMC9942740.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9215081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative study of the clinical characteristics and outcomes of HR-positive HER2-negative breast cancer patients over and under 65 years old. 65岁以上和65岁以下hr2阳性乳腺癌患者临床特征及转归的比较研究
Pub Date : 2021-06-01 DOI: 10.14216/kjco.21001
Chang Shin Jung, Youn Joo Jung, Dong Il Kim, Seungju Lee, Seok Kyung Kang, Su Bong Nam, Hyun Yul Kim

Purpose: The purpose of this study was to compare the clinical characteristics and outcomes of hormone receptor-positive (HR+) human epidermal growth factor 2-negative (HER2-) breast cancer among elderly patients (over 65 years old) and younger patients.

Methods: This was a retrospective cohort study of 328 patients who were treated for breast cancer at Pusan National University Yangsan Hospital between January 2009 and December 2014. Tumor characteristics, surgical methods, and survival outcomes were compared between the two age groups (<65 and ≥65 years old). Kaplan-Meier curves for disease-free survival (DFS) and overall survival (OS) were also constructed according to the age groups.

Results: Among the 328 patients with HR+ HER2- breast cancer, 184 (56.1%) were <65 years old and 144 (43.9%) were ≥65 years old. Breast cancer stages were similar between the two age groups, but the older patients were treated less often with chemotherapy (81% vs. 66%, P=0.002). During the follow-up period, 17 deaths and 36 cases of recurrence or metastasis were reported. There was no difference in DFS between the two groups (P=0.840); however, the OS of the older age group was significantly lower than that of the younger age group (P=0.015).

Conclusion: This study suggested that HR+ HER2- breast cancer patients belonging to the two age groups had no significant difference in DFS. However, older age is an independent factor affecting OS rate. Therefore, even if patients are old, but their physical condition is satisfactory, standard and active treatment may be necessary, similar to that given to younger patients.

目的:本研究的目的是比较老年患者(65岁以上)和年轻患者的激素受体阳性(HR+)人表皮生长因子2阴性(HER2-)乳腺癌的临床特征和预后。方法:对2009年1月至2014年12月在釜山国立大学梁山医院接受乳腺癌治疗的328例患者进行回顾性队列研究。结果:328例HR+ HER2-乳腺癌患者中,184例(56.1%)为:结论:本研究提示两组HR+ HER2-乳腺癌患者的DFS无显著差异。然而,年龄是影响OS率的独立因素。因此,即使患者年事已高,但其身体状况令人满意,也可能需要标准和积极的治疗,类似于对年轻患者的治疗。
{"title":"A comparative study of the clinical characteristics and outcomes of HR-positive HER2-negative breast cancer patients over and under 65 years old.","authors":"Chang Shin Jung,&nbsp;Youn Joo Jung,&nbsp;Dong Il Kim,&nbsp;Seungju Lee,&nbsp;Seok Kyung Kang,&nbsp;Su Bong Nam,&nbsp;Hyun Yul Kim","doi":"10.14216/kjco.21001","DOIUrl":"https://doi.org/10.14216/kjco.21001","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to compare the clinical characteristics and outcomes of hormone receptor-positive (HR+) human epidermal growth factor 2-negative (HER2-) breast cancer among elderly patients (over 65 years old) and younger patients.</p><p><strong>Methods: </strong>This was a retrospective cohort study of 328 patients who were treated for breast cancer at Pusan National University Yangsan Hospital between January 2009 and December 2014. Tumor characteristics, surgical methods, and survival outcomes were compared between the two age groups (<65 and ≥65 years old). Kaplan-Meier curves for disease-free survival (DFS) and overall survival (OS) were also constructed according to the age groups.</p><p><strong>Results: </strong>Among the 328 patients with HR+ HER2- breast cancer, 184 (56.1%) were <65 years old and 144 (43.9%) were ≥65 years old. Breast cancer stages were similar between the two age groups, but the older patients were treated less often with chemotherapy (81% vs. 66%, P=0.002). During the follow-up period, 17 deaths and 36 cases of recurrence or metastasis were reported. There was no difference in DFS between the two groups (P=0.840); however, the OS of the older age group was significantly lower than that of the younger age group (P=0.015).</p><p><strong>Conclusion: </strong>This study suggested that HR+ HER2- breast cancer patients belonging to the two age groups had no significant difference in DFS. However, older age is an independent factor affecting OS rate. Therefore, even if patients are old, but their physical condition is satisfactory, standard and active treatment may be necessary, similar to that given to younger patients.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2e/90/kjco-17-1-1.PMC9942741.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9513448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjuvant chemotherapy for patients with stage II high-risk and III colon cancer: Hindering factors to adherence and impact on long-term survival. II期和III期高危结肠癌患者的辅助化疗:阻碍依从性的因素及对长期生存的影响
Pub Date : 2021-06-01 DOI: 10.14216/kjco.21002
Jieun Kim, Ri Na Yoo, Hyeon-Min Cho, Bong-Hyeon Kye, Hyung Jin Kim

Purpose: Adjuvant chemotherapy is recommended after curative surgery in patients with colon cancer of high-risk stage II and stage III. However, a considerable number of patients cannot complete the scheduled adjuvant treatment for various reasons. This study investigates the hindering factors to the adherence to adjuvant chemotherapy and their impact on long-term survival.

Methods: A retrospective study was conducted for patients with colon cancer and had curative resection from 2009 to 2014. Among patients with pathologic stage II and III, stage II with low-risk features, double primary cancers, R2 resection cases were excluded. Patients were grouped into three groups: no-adjuvant therapy, adjuvant therapy for less than 3 months, and more than 3 months. Factors for withdrawal and the oncologic outcome were analyzed.

Results: Of 571 patients, adjuvant chemotherapy was recommended in 403. One hundred and sixteen patients (28.8%) did not receive adjuvant chemotherapy, 78 (19.4%) withdrew within 3 months, and 209 (51.9%) maintained for more than 3 months. Factors for not receiving adjuvant chemotherapy or withdrawing within 3 months were older than 70 and American Society of Anesthesiologists class 3 or higher. Main reasons for discontinuation before 3 months were chemotoxicity and patient's refusal. The long-term oncologic outcome of the patients who received adjuvant chemotherapy for more than 3 months was significantly better than others.

Conclusion: No-adjuvant therapy or receiving them for lesser than 3 months is significantly affected by the patient's performance status and social support, which coincides with a poor oncologic outcome. Social support and rehabilitation system may help to improve the survival outcome.

目的:结肠癌高危II期和III期患者在根治性手术后推荐辅助化疗。然而,相当一部分患者由于各种原因无法完成预定的辅助治疗。本研究探讨辅助化疗依从性的阻碍因素及其对长期生存的影响。方法:对2009 ~ 2014年行根治性手术的结肠癌患者进行回顾性分析。在病理分期为II期和III期、具有低危特征的II期、双原发癌的患者中,排除R2切除病例。将患者分为无辅助治疗组、辅助治疗时间小于3个月组和辅助治疗时间大于3个月组。分析停药的影响因素及肿瘤预后。结果:571例患者中,403例推荐辅助化疗。116例(28.8%)未接受辅助化疗,78例(19.4%)在3个月内退出,209例(51.9%)维持3个月以上。3个月内未接受辅助化疗或停药的因素为年龄大于70岁且美国麻醉医师学会3级及以上。3个月前停药的主要原因是化学毒性和患者拒绝。接受辅助化疗3个月以上的患者长期肿瘤预后明显优于其他患者。结论:无辅助治疗或接受辅助治疗少于3个月的患者的工作状态和社会支持对其有显著影响,这与不良的肿瘤预后相吻合。社会支持和康复系统可能有助于改善生存结果。
{"title":"Adjuvant chemotherapy for patients with stage II high-risk and III colon cancer: Hindering factors to adherence and impact on long-term survival.","authors":"Jieun Kim,&nbsp;Ri Na Yoo,&nbsp;Hyeon-Min Cho,&nbsp;Bong-Hyeon Kye,&nbsp;Hyung Jin Kim","doi":"10.14216/kjco.21002","DOIUrl":"https://doi.org/10.14216/kjco.21002","url":null,"abstract":"<p><strong>Purpose: </strong>Adjuvant chemotherapy is recommended after curative surgery in patients with colon cancer of high-risk stage II and stage III. However, a considerable number of patients cannot complete the scheduled adjuvant treatment for various reasons. This study investigates the hindering factors to the adherence to adjuvant chemotherapy and their impact on long-term survival.</p><p><strong>Methods: </strong>A retrospective study was conducted for patients with colon cancer and had curative resection from 2009 to 2014. Among patients with pathologic stage II and III, stage II with low-risk features, double primary cancers, R2 resection cases were excluded. Patients were grouped into three groups: no-adjuvant therapy, adjuvant therapy for less than 3 months, and more than 3 months. Factors for withdrawal and the oncologic outcome were analyzed.</p><p><strong>Results: </strong>Of 571 patients, adjuvant chemotherapy was recommended in 403. One hundred and sixteen patients (28.8%) did not receive adjuvant chemotherapy, 78 (19.4%) withdrew within 3 months, and 209 (51.9%) maintained for more than 3 months. Factors for not receiving adjuvant chemotherapy or withdrawing within 3 months were older than 70 and American Society of Anesthesiologists class 3 or higher. Main reasons for discontinuation before 3 months were chemotoxicity and patient's refusal. The long-term oncologic outcome of the patients who received adjuvant chemotherapy for more than 3 months was significantly better than others.</p><p><strong>Conclusion: </strong>No-adjuvant therapy or receiving them for lesser than 3 months is significantly affected by the patient's performance status and social support, which coincides with a poor oncologic outcome. Social support and rehabilitation system may help to improve the survival outcome.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a9/89/kjco-17-1-8.PMC9942742.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9513449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Erratum to: The current status of cancer survivorship care and a consideration of appropriate care model in Korea. 韩国癌症生存护理的现状和适当护理模式的考虑。
Pub Date : 2021-06-01 DOI: 10.14216/kjco.20024.e1
Hye Mi Ko, Je-Ryong Kim, Jin Sun Lee

[This corrects the article on p. 110 in vol. 16.].

[这是对第16卷第110页的文章的更正]。
{"title":"Erratum to: The current status of cancer survivorship care and a consideration of appropriate care model in Korea.","authors":"Hye Mi Ko,&nbsp;Je-Ryong Kim,&nbsp;Jin Sun Lee","doi":"10.14216/kjco.20024.e1","DOIUrl":"https://doi.org/10.14216/kjco.20024.e1","url":null,"abstract":"<p><p>[This corrects the article on p. 110 in vol. 16.].</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/df/c9/kjco-17-1-57.PMC9942738.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9210532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Korean journal of clinical oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1